SCAI

In a recent interview with @CardioBusiness, new SCAI President J. Dawn Abbott, MD, MSCAI, outlined her priorities, including workforce development, expanded training pathways, and continued efforts to broaden inclusion in the field. Watch and read the interview ➡️ ow.ly/9N3Z50YT6Je #InterventionalCardiology #CardioX

🚨 More from #SCAI2026🚨 Google searches for #TAVR surged among laypersons when pivotal trials were published, echoing the simultaneous clinical move away from surgical AVR in most patients. @SCAI #CardiacIntervention vist.ly/42w2r

Many of you are aware of recent media coverage on the considerations and challenges around aortic valve replacement options. SCAI has led the way in responding. Read the statement signed by SCAI, the American College of Cardiology, and the Society of Thoracic Surgeons ➡️ scai.org/media-center/n… #TAVR #InterventionalCardiology #CardioX #SCAIAdvocacy @ACCinTouch @STS_CTsurgery

We are incredibly proud of our resident, Dr. Smith Frimpong, for his standout oral and poster presentations at SCAI 2026 in Montréal this month. @GNECardFellows @WasiqueMirza #geisinger @SCAI

Wireless angiography-derived physiology (ADP) has the potential to address key limitations of invasive wire-based assessment by streamlining workflow and reducing costs and procedural time. In a SCAI roundtable, four experts discuss the advantages and limitations of ADP. Watch the roundtable discussion ➡️ youtu.be/lBlEdrSghxc?si… #InterventionalCardiology #CardioX @ESHLOF @wfearonmd @djkereiakes @B_Krogsgaard @myjscai

According to a recent clinical trial, automated electronic alerts improved referrals for valvular heart disease intervention which leads to improved outcomes for patients. The alerts can also reduce disparities in referral rates for repair or replacement for aortic stenosis and mitral regurgitation. Read more ➡️healio.com/news/cardiolog… #InterventionalCardiology @GoHealio

According to a new multicenter study, surgical #mitral valve replacement shows long-term survival advantages in patients with failing bioprosthetic mitral valves. “These findings support current guideline recommendations that favor surgical replacement in low-risk patients with longer life expectancy, while reserving transcatheter approaches for those at higher operative risk,” said S. Christopher Malaisrie, MD, lead author of the study. Read more ➡️ dicardiology.com/content/surgic… #CardioX @DAICeditor

⚠️ More from #SCAI2026 ⚠️ A novel #TMVR system designed for left atrial fixation rather than subvalvular fixation improved mitral regurgitation and functional outcomes in high surgical risk patients. @SCAI #CardiacIntervention vist.ly/42k4i

👏 As announced at #SCAI2026, welcome new SCAI President J. Dawn Abbott, MD, MSCAI! A nationally recognized leader in #InterventionalCardiology, her priorities include sustaining the interventional cardiology workforce by aligning certification and training with contemporary practice. Read more ➡️ scai.org/media-center/n… @JDawnAbbott1 @brownunivhealth

What are the most satisfying takeaways from mentorship? #SCAIMentorConnect

DETECT-AS substudy 🗝️ takeaways: ⚠️ Electronic provider notifications increased surgical and transcatheter AVR rates in older adults 🔔 Notifications may reduce age-related disparities in treatment of severe aortic stenosis @SCAI #InterventionalCardiology vist.ly/42dzg

Thank you to @SCAI for picking the beautiful city of @Montreal !! 🇨🇦 This was a special one! Many congratulations 🎉 to @JDawnAbbott1! Honored to be inducted as a brand new FSCAI and get a pic with the 2025 & 2026 presidents! #inspired #WIC #FSCAI #SCAI2026

There were tradeoffs for early adopters going the transradial route for infrainguinal peripheral artery intervention, according to a retrospective study using data from the XLPAD registry. @SCAI #SCAI2026 medpagetoday.com/meetingcoverag…

At #SCAI2026 presenting our meta-analysis and systematic review on DOAC vs DAPT after LAAC. DOAC had less bleeding, less device-related thrombosis, and no increase in stroke or systemic thromboembolization @AravJhandMD Overall, had a blast and it was a great conference

There was a survival advantage to having hospitals with mechanical circulatory support escalation capabilities treat people with acute myocardial infarction with cardiogenic shock, according to registry data. @SCAI #SCAI2026 medpagetoday.com/meetingcoverag…

The AltaValve transcatheter mitral valve replacement system had sustained effects among patients with severe mitral regurgitation out to 1 year, according to an early feasibility study. @SCAI #SCAI2026 medpagetoday.com/meetingcoverag…

Cardiovascular protection with GLP-1 receptor agonists may benefit patients undergoing certain transcatheter procedures, according to two observational studies. #SCAI2026 @SCAI medpagetoday.com/meetingcoverag…

I’m honored to be named one of SCAI’s 30 in Their 30 recipients for 2026 and to be inducted as a Fellow of @SCAI. I’m deeply grateful for the guidance, mentorship, and support of those who made this milestone possible. @kalazizimd @Babar_Basir @mszerlip @herbaronowMD @PedroMDMSc

👏 It’s been a great year! From establishing Door-to-Lactate Clearance within 24 hours for #CardiogenicShock, to expanding our health, safety, and wellness efforts, SCAI is building a foundation for the future of #InterventionalCardiology! Read the SCAI Presidential Year in Review by Srihari S. Naidu, MD, MSCAI ➡️ ow.ly/mW5L50YPGP0 @SrihariNaiduMD

⚠️ More from #SCAI2026 ⚠️ Electronic provider notifications may close gaps in referral for treatment of severe aortic stenosis vs. usual care among older patients. @SCAI #InterventionalCardiology vist.ly/4242a